Publications by authors named "Francesco Autore"

Claim this Profile
F
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study.
Alberto Fresa, Idanna Innocenti, Annamaria Tomasso, Candida Vitale, Alessandro Sanna, Francesco Autore

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib increases miR-181a/b in leukemic cells from patients with chronic lymphocytic leukemia.
Alice Ramassone, Sara Pagotto, Mirco Di Marco, Mohammad Mamunur Rashid, Carola Di Camillo, Francesco Autore

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose thiotepa may induce inappropriate secretion of antidiuretic hormone syndrome (SIADH) during conditioning treatment for allogeneic stem cell transplantation.
Maria Assunta Limongiello, Elisabetta Metafuni, Sabrina Giammarco, Eugenio Galli, Federica Sorà, Francesco Autore

Int J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report of Consensus Panel 5 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors.
Jorge J Castillo, Francesco Autore, Neil L Berinstein, Andrew R Branagan, Meletios A Dimopoulos

Semin Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report of Consensus Panel 4 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphoma.
Alessandra Tedeschi, Rebecca Auer, Francesco Autore, Jorge J Castillo, Moshe E Gatt

Semin Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation.
Francesco Autore, Daniele Mannina, Federica Lessi, Eugenio Galli, Stefania Oliva

Hematol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemia.
Anna Maria Frustaci, Arianna Zappaterra, Andrea Galitzia, Andrea Visentin, Michele Merli, Francesco Autore

Hemasphere· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?
Francesco Autore, Andrea Visentin, Marina Deodato, Candida Vitale, Eugenio Galli

Blood Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies.
Francesco Autore, A Tedeschi, G Benevolo, V Mattiello, E Galli

Am J Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience.
Idanna Innocenti, Tommaso Quaranta, Annamaria Tomasso, Antonio Mosca, Giulia Benintende, Francesco Autore

Hematol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience.
Idanna Innocenti, Annamaria Tomasso, Diana Giannarelli, Lydia Scarfò, Roberta Murru, Francesco Autore

Hematol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life benefits of arsenic trioxide in patients with non-high-risk acute promyelocytic leukemia are sustained over time: long-term results of the GIMEMA APL0406 trial.
Fabio Efficace, Francesco Sparano, Massimo Breccia, Corinna Greco, Paola Carluccio, Francesco Autore

Ann Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience.
Idanna Innocenti, Antonio Mosca, Annamaria Tomasso, Andrea Galitzia, Lydia Scarfò, Francesco Autore

Hemasphere· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapsed/refractory pure red cell aplasia in chronic lymphocytic leukemia successfully treated with acalabrutinib: a case report and review of the literature.
Alberto Fresa, Idanna Innocenti, Annamaria Tomasso, Luca Stirparo, Antonio Mosca, Francesco Autore

Ther Adv Hematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttransplant Autoimmune Hemolytic Anemia with Anti-D Specificity Successfully Treated with Daratumumab: A Case Report.
Filippo Frioni, Elisabetta Metafuni, Maria Assunta Limongiello, Nicola Piccirillo, Giuseppina Massini, Francesco Autore

Transfus Med Hemother· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PlentiPlex™ MYD88 Waldenström lymphoma qPCR assay: A highly sensitive method for detection of MYD88 L265P mutation.
Marcello Viscovo, Mia de Laurent Clemmensen, Federica Fosso, Elena Maiolo, Francesco Autore

Int J Lab Hematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study.
Francesco Autore, Andrea Visentin, Marina Deodato, Candida Vitale, Eugenio Galli

Am J Hematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed.
Alberto Fresa, Idanna Innocenti, Annamaria Tomasso, Luca Stirparo, Antonio Mosca, Francesco Autore

Cancers (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome?
Francesco Autore, Stefania Bramanti, Federica Lessi, Idanna Innocenti, Eugenio Galli

Haematologica· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T-cells (CAR-T): A comprehensive review on incidence, risk factors and current management.
Eugenio Galli, Alberto Fresa, Silvia Bellesi, Elisabetta Metafuni, Elena Maiolo, Francesco Autore

Eur J Haematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study.
Giovanni D'Arena, Candida Vitale, Giuseppe Pietrantuono, Oreste Villani, Giovanna Mansueto, Francesco Autore

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study.
Francesco Autore, Idanna Innocenti, Gianluigi Reda, Andrea Visentin, Candida Vitale

Hematol Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience.
Idanna Innocenti, Alberto Fresa, Annamaria Tomasso, Michela Tarnani, Laura De Padua, Francesco Autore

Cancers (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of microRNAs in Chronic Lymphocytic Leukemia.
Francesco Autore, Alice Ramassone, Luca Stirparo, Sara Pagotto, Alberto Fresa

Int J Mol Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual disease in chronic lymphocytic leukemia.
Giulia Benintende, Federico Pozzo, Idanna Innocenti, Francesco Autore, Alberto Fresa

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis